Effects of TDCS of the Frontal Lobe on Cognitive Function and BDNF in PSCI - Trial NCT06386614
Access comprehensive clinical trial information for NCT06386614 through Pure Global AI's free database. This phase not specified trial is sponsored by The Second Affiliated Hospital of Dalian Medical University and is currently Recruiting. The study focuses on Stroke. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
The Second Affiliated Hospital of Dalian Medical University
Timeline & Enrollment
N/A
Jan 01, 2023
Jun 01, 2024
Primary Outcome
BDNF
Summary
The purpose of the clinical trial is to find a treatment for stroke patients with cognitive
 impairment, and the main questions it aims to answer are:
 
 - [Search for effective treatments of cognitive impairment after stroke]
 
 - [explore the relationship between BDNF level and cognitive function] Participants will
 receive conventional treatment, tDCS treatment, .And then compare cognitive function and
 BDNF level
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06386614
Non-Device Trial